Blood News and Research

RSS

Yale research supports MRD detection for post-treatment lung cancer care

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with lung cancer years after their treatment.

17 Mar 2025

Congenital heart defects may be linked to increased cancer risk in babies and mothers

Being born with a heart defect may be associated with an increased cancer risk for babies and their moms, according to new research published today in the American Heart Association's flagship journal Circulation.

17 Mar 2025

Polluted soil and water are fueling a global heart disease epidemic

A new study in Atherosclerosis shows that soil and water pollution, including microplastics and toxic chemicals, significantly raise cardiovascular disease risks. The research highlights how emerging contaminants and poor environmental practices drive global health threats.

16 Mar 2025

Open-source AI tool competes with leading proprietary models in medical diagnosis

Artificial intelligence can transform medicine in a myriad of ways, including its promise to act as a trusted diagnostic aide to busy clinicians.

14 Mar 2025

New CRISPR-based test detects multi-drug-resistant bacteria without amplification

Bioengineering professor and The Grainger College of Engineering's Dean, Rashid Bashir, led a team of researchers in a project that's resulted in new technology that offers rapid, highly sensitive detection of multi-drug-resistant bacteria and other pathogens at low concentrations.

14 Mar 2025

New AI model can estimate biological age using blood samples

We all know someone who seems to defy aging-people who look younger than their peers despite being the same age.

14 Mar 2025

Blood-brain barrier dysfunction and inflammation linked to Down syndrome Regression Disorder

A new research study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children's Hospital Los Angeles, shows evidence of dysfunction of the blood-brain barrier and inflammation in the central nervous system in individuals with Down syndrome Regression Disorder (DSRD).

14 Mar 2025

New scientific clue could unlock key cellular pathway leading to neurodegenerative diseases

In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like Alzheimer's disease, and the progressive damage to the brain's frontal and temporal lobes in frontotemporal degeneration (FTD) and the associated disease amyotrophic lateral sclerosis (ALS).

14 Mar 2025

Advances in organ preservation techniques and future prospects

A review article published in Engineering delves into the crucial field of organ preservation, exploring its history, current techniques, and future prospects.

14 Mar 2025

Long-COVID symptoms persist for two years in over half of cases

23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.

14 Mar 2025

Bioenergetic age could predict Alzheimer's disease risk

A person's "bioenergetic age"-or how youthfully their cells generate energy-might be a key indicator of whether they're at risk of developing Alzheimer's disease, new research from Weill Cornell Medicine shows.

14 Mar 2025

National survey reveals high public interest in medically tailored food programs

Researchers have conducted the first national survey on public awareness and perceptions of food, health, and Food is Medicine programs.

14 Mar 2025

NIH researchers define topical steroid withdrawal diagnostic criteria

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid withdrawal (TSW) is distinct from eczema and is caused by an excess of an essential chemical compound in the body.

14 Mar 2025

Groundbreaking stem cell therapy trial for Alzheimer's disease underway at UTHealth Houston

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.

14 Mar 2025

New therapeutic approach shows promise for pediatric high-grade gliomas

Brain tumors remain the most common cause of death from childhood cancer. Paediatric high-grade gliomas (pHGG) in particular are a mostly fatal disease group with a median survival time of less than 18 months after diagnosis and limited treatment options.

14 Mar 2025

Social advantage reduces risk of age-related diseases and slows aging

People with favorable socioeconomic conditions, such as high incomes or education levels, face a reduced risk of age-related diseases and show fewer signs of biological aging than peers of the same age, finds a new study led by University College London (UCL) researchers.

14 Mar 2025

CityUHK leads groundbreaking project to develop new platform for early cancer detection

Cancer continues to be a leading cause of mortality worldwide, highlighting the urgent need to develop more advanced, efficient, and early detection methods.

13 Mar 2025

IRENE network enhances stroke care and patient outcomes in Europe

Stroke can come out of the blue, even in people who have been healthy all their lives. Unlike some other health conditions that develop gradually, a stroke occurs suddenly when blood flow to the brain is blocked in a cerebral artery, causing the brain to essentially stop functioning almost immediately. What's remarkable about stroke treatment is its extreme time sensitivity.

13 Mar 2025

Study shows impact of statins and aspirin on muscle health in smokers

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

13 Mar 2025

Firefighting chemicals leave brain cancer-linked mutations, study shows

Firefighters show higher rates of glioma-linked SBS42 mutational signatures associated with haloalkane exposure, suggesting occupational risk. The study highlights a clear link between firefighting, chemical exposure, and brain cancer mutations.

13 Mar 2025

Blood News and Research

Yale research supports MRD detection for post-treatment lung cancer care

Congenital heart defects may be linked to increased cancer risk in babies and mothers

Polluted soil and water are fueling a global heart disease epidemic

Open-source AI tool competes with leading proprietary models in medical diagnosis

New CRISPR-based test detects multi-drug-resistant bacteria without amplification

New AI model can estimate biological age using blood samples

Blood-brain barrier dysfunction and inflammation linked to Down syndrome Regression Disorder

New scientific clue could unlock key cellular pathway leading to neurodegenerative diseases

Advances in organ preservation techniques and future prospects

Long-COVID symptoms persist for two years in over half of cases

Bioenergetic age could predict Alzheimer's disease risk

National survey reveals high public interest in medically tailored food programs

NIH researchers define topical steroid withdrawal diagnostic criteria

Groundbreaking stem cell therapy trial for Alzheimer's disease underway at UTHealth Houston

New therapeutic approach shows promise for pediatric high-grade gliomas

Social advantage reduces risk of age-related diseases and slows aging

CityUHK leads groundbreaking project to develop new platform for early cancer detection

IRENE network enhances stroke care and patient outcomes in Europe

Study shows impact of statins and aspirin on muscle health in smokers

Firefighting chemicals leave brain cancer-linked mutations, study shows

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News